Related references
Note: Only part of the references are listed.Antibodies to watch in 2014 Mid-year update
Janice M. Reichert
MABS (2014)
Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC Overview and applications
Mark Haverick et al.
MABS (2014)
Assessment of chemical modifications of sites in the CDRs of recombinant antibodies Susceptibility vs. functionality of critical quality attributes
Markus Haberger et al.
MABS (2014)
Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction
Kai Zhu et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2014)
Characterization of Therapeutic Antibodies and Related Products
Alain Beck et al.
ANALYTICAL CHEMISTRY (2013)
Which are the antibodies to watch in 2013?
Janice M. Reichert
MABS (2013)
Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies
Yi Du et al.
MABS (2012)
Disulfide bond structures of IgG molecules Structural variations, chemical modifications and possible impacts to stability and biological function
Hongcheng Liu et al.
MABS (2012)
Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody
Josef Vlasak et al.
ANALYTICAL BIOCHEMISTRY (2009)
MASS SPECTROMETRY FOR STRUCTURAL CHARACTERIZATION OF THERAPEUTIC ANTIBODIES
Zhongqi Zhang et al.
MASS SPECTROMETRY REVIEWS (2009)
Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry
John Valliere-Douglass et al.
ANALYTICAL CHEMISTRY (2008)
Heterogeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods
J. Vlasak et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions
John Valliere-Douglass et al.
JOURNAL OF CHROMATOGRAPHY A (2008)
Removal of cysteinylation from an unpaired sulfhydryl in the variable region of a recombinant monoclonal IgG1 antibody improves homogeneity, stability, and biological activity
Douglas D. Banks et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab
James A. Lofgren et al.
JOURNAL OF IMMUNOLOGY (2007)
Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals
Catherine A. Srebalus Barnes et al.
MASS SPECTROMETRY REVIEWS (2007)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody using Lys-C limited proteolysis coupled with LC/MS analysis
Himanshu S. Gadgil et al.
ANALYTICAL BIOCHEMISTRY (2006)
Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies
Christina Boozer et al.
CURRENT OPINION IN BIOTECHNOLOGY (2006)
Structural characterization of a recombinant monoclonal antibody by electrospray time-of-flight mass spectrometry
LT Wang et al.
PHARMACEUTICAL RESEARCH (2005)
Protein S-thiolation targets glycolysis and protein synthesis in response to oxidative stress in the yeast Saccharomyces cerevisiae
D Shenton et al.
BIOCHEMICAL JOURNAL (2003)
Free sulfhydryl in recombinant monoclonal antibodies
W Zhang et al.
BIOTECHNOLOGY PROGRESS (2002)
Identification of multiple sources of charge heterogeneity in a recombinant antibody
RJ Harris et al.
JOURNAL OF CHROMATOGRAPHY B (2001)